Hematology and Oncology Consultants PC
Omaha, Nebraska, United States
Cancer treatment center in Omaha, Nebraska
7500 Mercy Rd, Omaha, NE 68124
About Hematology and Oncology Consultants PC
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Hematology and Oncology Consultants PC
During the past decade, Hematology and Oncology Consultants PC conducted 62 clinical trials. In the 10-year time frame, 62 clinical trials started and 44 clinical trials were completed, i.e. on
average, 71% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 35 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Chemotherapy, Imatinib Mesylate, and Peripheral Stem Cell Transplantation in Treating Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
2002-04-01
2014-02-01
Completed
58
Four Versus Six Cycles of Cyclophosphamide/Doxorubicin or Paclitaxel in Adjuvant Breast Cancer
2002-05-01
2014-06-01
Completed
3,871
S0124: Cisplatin Combined With Irinotecan or Etoposide For Extensive-Stage Small Cell Lung Cancer
2002-11-01
2009-12-01
Completed
671
Chemotherapy and Radiation Therapy After Surgery in Treating Patients With Stomach or Esophageal Cancer
2002-12-01
2016-12-01
Completed
546
Triptorelin With Either Exemestane or Tamoxifen in Treating Premenopausal Women With Hormone-Responsive Breast Cancer
2003-11-03
2025-12-01
Active, not recruiting
2,672
Chemotherapy Decisions and Outcomes in Older Women With Newly Diagnosed Breast Cancer
2003-08-01
2016-12-01
Completed
1,706
S0221 Adjuvant Doxorubicin, Cyclophosphamide, and Paclitaxel in Treating Patients With Breast Cancer
2003-11-01
2027-01-01
Active, not recruiting
3,294
Comparison of Combination Chemotherapy Regimens With or Without Cetuximab in Treating Patients Who Have Undergone Surgery For Stage III Colon Cancer
2004-02-01
2012-11-01
Completed
3,397
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Hematology and Oncology Consultants PC" #1 sponsor was "National Cancer Institute (NCI)" with 49 trials, followed by "SWOG Cancer Research Network" with 24 trials
sponsored, "Alliance for Clinical Trials in Oncology" with 13 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 8 trials sponsored and "Children's Oncology Group"
with 8 trials sponsored. Other sponsors include 4 different institutions and
companies that sponsored additional 11 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Hematology and Oncology Consultants PC"
#1 collaborator was "National Cancer Institute (NCI)" with 52 trials as a collaborator, "NRG Oncology" with 13 trials as a collaborator, "Canadian Cancer Trials Group" with 5 trials as a collaborator, "Agenus Inc." with 1 trials as a collaborator and "Bayer" with 1 trials as a collaborator. Other collaborators include 5 different institutions and companies that were
collaborators in the rest 15 trials.
Clinical Trials Conditions at Hematology and Oncology Consultants PC
According to Clinical.Site data, the most researched conditions in "Hematology and Oncology Consultants PC" are
"Recurrent Squamous Cell Lung Carcinoma" (7 trials), "Recurrent Ovarian Carcinoma" (6 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (6 trials), "Recurrent Breast Carcinoma" (5 trials) and "Recurrent Fallopian Tube Carcinoma" (4 trials). Many other conditions were trialed in "Hematology and Oncology Consultants PC" in a lesser frequency.
Clinical Trials Intervention Types at Hematology and Oncology Consultants PC
Most popular intervention types in "Hematology and Oncology Consultants PC" are "Drug" (82 trials), "Other" (70 trials), "Biological" (46 trials), "Procedure" (24 trials) and "Radiation" (7 trials). Other intervention types were less common.
The name of intervention was led by "Laboratory Biomarker Analysis" (44 trials), "Quality-of-Life Assessment" (22 trials), "Nivolumab" (15 trials), "Cisplatin" (13 trials) and "Carboplatin" (12 trials). Other intervention names were less common.
Clinical Trials Genders at Hematology and Oncology Consultants PC
The vast majority of trials in "Hematology and Oncology Consultants PC" are
80 trials for "All" genders, 23 trials for "Female" genders and 2 trials for "Male" genders.
Clinical Trials Status at Hematology and Oncology Consultants PC
Currently, there are NaN active trials in "Hematology and Oncology Consultants PC".
undefined are not yet recruiting,
15 are recruiting,
62 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 21 completed trials in Hematology and Oncology Consultants PC,
undefined suspended trials,
and 6 terminated clinical trials to date.
Out of the total trials that were conducted in Hematology and Oncology Consultants PC, 3 "Phase 1"
clinical trials were conducted, 51 "Phase 2" clinical
trials and 53 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 2 trials that are defined as “Not Applicable".